Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy
Top Cited Papers
- 26 March 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (12) , 1407-1411
- https://doi.org/10.1161/01.cir.0000012626.81324.38
Abstract
Background— Although studies have suggested that “late-onset” hypertrophic cardiomyopathy (HCM) may be caused by sarcomeric protein gene mutations, the cause of HCM in the majority of patients is u...Keywords
This publication has 10 references indexed in Scilit:
- Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's DiseaseNew England Journal of Medicine, 2001
- Enzyme Replacement Therapy in Fabry DiseaseJAMA, 2001
- New insights in cardiac structural changes in patients with Fabry’s diseaseAmerican Heart Journal, 2000
- The Management of Hypertrophic CardiomyopathyNew England Journal of Medicine, 1997
- An Atypical Variant of Fabry's Disease in Men with Left Ventricular HypertrophyNew England Journal of Medicine, 1995
- Sequence variations in the first exon of alpha-galactosidase A.Journal of Medical Genetics, 1993
- Mutation analysis in patients with the typical form of Anderson — Fabry diseaseHuman Molecular Genetics, 1993
- Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A reviewProgress in Cardiovascular Diseases, 1985
- Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathyThe American Journal of Cardiology, 1981
- A point-score system for the ECG diagnosis of left ventricular hypertrophyAmerican Heart Journal, 1968